ResMed | RMD - Operating Expenses

Stock Price
224.09
Daily Change
1.24 0.56%
Monthly
-13.24%
Yearly
5.03%
Q2 Forecast
217.34

ResMed reported $925.21M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Ansell USD 880.1M 465.65M Dec/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 138.01M 3.95M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Cochlear AUD 914.9M 454.8M Dec/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
CSL USD 5.7B 2.82B Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Fisher Paykel Healthcare NZD 802.4M 24.1M Dec/2025
Globus Medical USD 645.11M 241.46M Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Idexx Laboratories USD 774.97M 24.58M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
Masimo USD 328.6M 181.6M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Philips EUR 4.38B 405M Dec/2025
Ramsay Health Care AUD 8.8B 83.5M Dec/2025
ResMed USD 925.21M 51.98M Dec/2025
Sigma Healthcare AUD 1.68B 174.89M Dec/2024
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Steris USD 1.22B 28.8M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025